ClinConnect ClinConnect Logo
Search / Trial NCT01442506

Acetic Acid Guided Biopsies Compared With High Definition Endoscopy in the Detection of Barrett's Esophagus

Launched by JOHANNES GUTENBERG UNIVERSITY MAINZ · Sep 27, 2011

Trial Information

Current as of May 08, 2025

Unknown status

Keywords

Acetic Acid Virtual Chromoendosopy

ClinConnect Summary

Specialized columnar epithelium (SCE) is considered as pathognomonic for Barrett's esophagus and can be recognized by new endoscopic techniques. Aim of the study is to test the efficacy of HD+ endoscopy in conjunction with i-scan (newly developed post processing digital filter) or chromoendoscopy (acetic acid) to diagnose Barrett's esophagus.

Patients with visible columnar lined lower esophagus (CLE) or known Barrett's esophagus are included. After standardized PPI therapy (14 days; standard dosage) patients are randomized at a 1:1 ratio to undergo either chromoendoscopy in conjunction wit...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with CLE
  • patients with known Barrett's esophagus
  • Exclusion Criteria:
  • pregnancy
  • severe coagulopathy
  • known malignancies

About Johannes Gutenberg University Mainz

Johannes Gutenberg University Mainz, a leading research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research and education to address critical health challenges. Its commitment to ethical standards and scientific rigor ensures that clinical trials are conducted with the utmost integrity, aiming to translate research findings into effective therapies and improved patient outcomes. Through its robust infrastructure and expert faculty, Johannes Gutenberg University Mainz plays a pivotal role in enhancing the landscape of clinical research and contributing to global health advancements.

Locations

Mainz, , Germany

Patients applied

0 patients applied

Trial Officials

Arthur Hoffman, MD

Principal Investigator

Johannes Gutenberg University Mainz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials